Brief: Oncozenge And Yangtian Pharma Enter Into Amendment To Investment Agreement
25/04/2025 07:36
April 25 (Reuters) - Oncozenge AB ONCOZ.ST: ONCOZENGE AND YANGTIAN PHARMA ENTERED INTO AMENDMENT TO INVESTMENT AGREEMENT TIMEFRAME OF ODI PROCESS BEING EXTENDED TO MAY 31ST, 2025, ALL OTHER TERMS UNAFFECTED Source text: ID:nWkr9BN8d8 Further company coverage: ONCOZ.ST (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))